Pharmaceuticals news FT.com

Germany’s Merck to buy US biotech SpringWorks for $3.9bn

Pharmaceutical group says deal will help it establish leadership in treating rare tumours

May 12, 2025 - 10:14
 0
Germany’s Merck to buy US biotech SpringWorks for $3.9bn
Pharmaceutical group says deal will help it establish leadership in treating rare tumours
Read More

Tags:

Previous Article

AstraZeneca ‘committed’ to US manufacturing as profits rise

Next Article

Pharma bosses call for higher drug prices in EU to counter tariff threat

Related Posts

Biotech billionaire Christian Angermayer: ‘Psychedelics can take away the fear’

Biotech billionaire Christian Angermayer: ‘Psychedelics...

May 18, 2025  0

J&J warns pharma tariffs could cause drug shortages

J&J warns pharma tariffs could cause drug shortages

May 12, 2025  0

UnitedHealth shares plunge further as chief Andrew Witty steps down

UnitedHealth shares plunge further as chief Andrew Witt...

May 13, 2025  0